Nicholas Papadopoulos

5.0k total citations · 3 hit papers
53 papers, 3.6k citations indexed

About

Nicholas Papadopoulos is a scholar working on Molecular Biology, Astronomy and Astrophysics and Surgery. According to data from OpenAlex, Nicholas Papadopoulos has authored 53 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Astronomy and Astrophysics and 9 papers in Surgery. Recurrent topics in Nicholas Papadopoulos's work include Angiogenesis and VEGF in Cancer (14 papers), Stellar, planetary, and galactic studies (8 papers) and Quantum chaos and dynamical systems (8 papers). Nicholas Papadopoulos is often cited by papers focused on Angiogenesis and VEGF in Cancer (14 papers), Stellar, planetary, and galactic studies (8 papers) and Quantum chaos and dynamical systems (8 papers). Nicholas Papadopoulos collaborates with scholars based in United States, Greece and Italy. Nicholas Papadopoulos's co-authors include George D. Yancopoulos, Gavin Thurston, Christopher Daly, Neil Stahl, Stanley J. Wiegand, Hsin Chieh Lin, Joel Martin, Ashique Rafique, Sandra Coetzee and Irene Noguera‐Troise and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nicholas Papadopoulos

52 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

2006 824 citations Irene Noguera‐Troise, Christopher Daly et al. Nature profile →
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

2012 823 citations Nicholas Papadopoulos, Joel Martin et al. Angiogenesis profile →
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

2019 330 citations Joel Martin, Ashique Rafique et al. profile →

Peers

Countries citing papers authored by Nicholas Papadopoulos

Since Specialization

Citations

This map shows the geographic impact of Nicholas Papadopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Papadopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Papadopoulos more than expected).

Fields of papers citing papers by Nicholas Papadopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Papadopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Papadopoulos. The network helps show where Nicholas Papadopoulos may publish in the future.

Co-authorship network of co-authors of Nicholas Papadopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Papadopoulos. A scholar is included among the top collaborators of Nicholas Papadopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Papadopoulos. Nicholas Papadopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids 2020 ·Bioorganic & Medicinal Chemistry ·Thomas Nittoli, Frank J. Delfino, Marcus P. Kelly, (unknown), (unknown), Arthur Kunz, Zhaoyuan Chen, Shu Mao, Jing Shan, Elizabeth Navarro, Feng Zhao, Sosina Makonnen, Carlos Hickey, (unknown), William C. Olson, Jessica R. Kirshner, Gavin Thurston, Nicholas Papadopoulos	4
2	Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor 2018 ·Scientific Reports ·Christopher Daly, Xiaozhong Qian, Carla Castanaro, Elizabeth Pasnikowski, (unknown), Benjamin R. Thomson, Susan E. Quaggin, Nicholas Papadopoulos, (unknown), John S. Rudge, Gavin Thurston, George D. Yancopoulos, Samuel Davis	36
3	Myostatin deficiency but not anti‐myostatin blockade induces marked proteomic changes in mouse skeletal muscle 2016 ·PROTEOMICS ·(unknown), (unknown), Anthony Doré, (unknown), Lawrence Miloscio, Esther Latres, Nicholas Papadopoulos, William C. Olson, Douglas MacDonald, Xunbao Duan	13
4	Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer 2015 ·Cancer Research ·Frank Kuhnert, Guoying Chen, Sandra Coetzee, (unknown), Carlos Hickey, Jing Shan, Pavel Kovalenko, Irene Noguera‐Troise, Eric Smith, Jeanette Fairhurst, Julian Andreev, Jessica R. Kirshner, Nicholas Papadopoulos, Gavin Thurston	37
5	A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys 2015 ·Scientific Reports ·Eric Smith, Kara Olson, Lauric Haber, Bindu Varghese, Paurene Duramad, Andrew D. Tustian, A. Oyejide, Jessica R. Kirshner, (unknown), Jayanthi Menon, (unknown), Douglas MacDonald, Joel Kantrowitz, Nicholas Papadopoulos, Neil Stahl, George D. Yancopoulos, Gavin Thurston, Samuel Davis	122
6	Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition 2012 ·Cancer Research ·Christopher Daly, Alexandra Eichten, Carla Castanaro, Elizabeth Pasnikowski, Alexander P. Adler, Alshad S. Lalani, Nicholas Papadopoulos, Alastair H. Kyle, Andrew I. Minchinton, George D. Yancopoulos, Gavin Thurston	180
7	Reduction of LDL cholesterol by a monoclonal antibody to PCSK9 in rodents and nonhuman primates 2012 ·Clinical Lipidology ·Viktoria Gusarova, Victor Howard, Haruka Okamoto, (unknown), Nicholas Papadopoulos, Andrew Murphy, George D. Yancopoulos, Neil Stahl, Mark W. Sleeman	7
8	Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab breakdown → 2012 ·Angiogenesis ·Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael Rosconi, Ergang Shi, Erica Pyles, George D. Yancopoulos, Neil Stahl, Stanley J. Wiegand	823
9	Abstract 2718: REGN1400, a fully-human ERBB3 antibody, potently inhibits tumor growth in preclinical models, both as a monotherapy and in combination with EGFR or HER2 blockers 2012 ·Cancer Research ·Li Zhang, (unknown), (unknown), Carla Castanaro, Nicholas Papadopoulos, Gavin Thurston, Christopher Daly	4
10	Modeling the dynamical profile of a BL Lacertae object 2008 ·Astronomische Nachrichten ·Nicholas Papadopoulos, N. D. Caranicolas	1
11	Rapid effects of VEGF Trap on angiogenesis and tumor cell proliferation 2007 ·Cancer Research ·Alexander P. Adler, Baosheng Li, (unknown), Darya Burakov, Nicholas Papadopoulos, Gavin Thurston	1
12	Blockade of Dll4 Inhibits Tumour Growth by Promoting Non‐Productive Angiogenesis 2007 ·Novartis Foundation symposium ·Irene Noguera‐Troise, Christopher Daly, Nicholas Papadopoulos, Sandra Coetzee, (unknown), Nicholas W. Gale, Hsin Chieh Lin, George D. Yancopoulos, Gavin Thurston	65
13	Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis breakdown → 2006 ·Nature ·Irene Noguera‐Troise, Christopher Daly, Nicholas Papadopoulos, Sandra Coetzee, (unknown), Nicholas W. Gale, Hsin Chieh Lin, George D. Yancopoulos, Gavin Thurston	824
14	The anti-inflammatory actions of angiopoietin-1 2005 ·Birkhäuser Basel eBooks ·Gavin Thurston, John S. Rudge, Ella Ioffe, Nicholas Papadopoulos, Christopher Daly, (unknown), Thomas J. Daly, Stanley J. Wiegand, George D. Yancopoulos	16
15	Chaotic orbits in a galaxy model with a massive nucleus 2003 ·Astronomy and Astrophysics ·N. D. Caranicolas, Nicholas Papadopoulos	16
16	Binding of Longer Peptides to the H-2Kb Heterodimer Is Restricted to Peptides Extended at Their C Terminus: Refinement of the Inherent MHC Class I Peptide Binding Criteria 1999 ·The Journal of Immunology ·Heidi Hörig, Aideen C. M. Young, Nicholas Papadopoulos, Teresa P. DiLorenzo, Stanley G. Nathenson	40
17	Primary sarcomas of the kidney. A clinicopathologic and dna flow cytometric study of 17 cases 1990 ·Cancer ·David J. Grignon, Alberto G. Ayala, Jae Y. Ro, Adel K. El‐Naggar, Nicholas Papadopoulos	36
18	Electron spin-echo studies of the copper(II) binding sites in dopamine .beta.-hydroxylase 1988 ·Biochemistry ·(unknown), Parimal R. Desai, Nicholas Papadopoulos, Joseph J. Villafranca, J. Peisach	50
19	Arterial Segmentation of the Human Spleen by Post-Mortem Angiograms and Corrosion-Casts 1982 ·Angiology ·(unknown), (unknown), Nicholas Papadopoulos	12
20	Spontaneous CP-violation in the Weinberg-Salam model 1977 ·Lettere al nuovo cimento della societa italiana di fisica/Lettere al nuovo cimento ·A.B. Lahanas, Nicholas Papadopoulos	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact